- Their first goal is to secure the technology to produce a vaccine using synthetic messenger RNA, or mRNA.
- The Korean consortium aims to begin production of its COVID-19 vaccine next year to help the country overcome the ongoing pandemic. Its target is at least 100 million doses.
- The companies say they will work to expand their manufacturing capacity to 1 billion doses by 2023.
http://www.koreaherald.com/view.php?ud=20210629001020